The development of optimal pathological assessment of sentinel lymph nodes for melanoma
Martin Cook(Royal Surrey NHS Foundation Trust), Barry Powell(St George's Hospital), Brian Anderson(NZOZ Centrum Alergologii), Alexander M.M. Eggermont(University Medical Center Utrecht), Alan Spatz(Jewish General Hospital), Dirk J. Ruiter(Radboud University Nijmegen), Mark Kissin(Royal Surrey County Hospital), Margaret A. Green(Royal Surrey County Hospital)
Cited by 196
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k